Literature DB >> 16045741

An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes.

G Bouma1, J M C Coppens, W-K Lam-Tse, W Luini, K Sintnicolaas, W H Levering, S Sozzani, H A Drexhage, M A Versnel.   

Abstract

In the early development of type 1 diabetes macrophages and dendritic cells accumulate around the islets of Langerhans at sites of fibronectin expression. It is thought that these macrophages and dendritic cells are derived from blood monocytes. Previously, we showed an increased serum level of MRP8/14 in type 1 diabetes patients that induced healthy monocytes to adhere more strongly to fibronectin (FN). Here we show that MRP8/14 is expressed and produced at a higher level by type 1 diabetes monocytes, particularly after adhesion to FN, creating a positive feedback mechanism for a high fibronectin-adhesive capacity. Also adhesion to endothelial cells was increased in type 1 diabetes monocytes. Despite this increased adhesion the transendothelial migration of monocytes of type 1 diabetes patients was decreased towards the proinflammatory chemokines CCL2 and CCL3. Because non-obese diabetic (NOD) mouse monocytes show a similar defective proinflammatory migration, we argue that an impaired monocyte migration towards proinflammatory chemokines might be a hallmark of autoimmune diabetes. This hampered monocyte response to proinflammatory chemokines questions whether the early macrophage and dendritic cell accumulation in the diabetic pancreas originates from an inflammatory-driven influx of monocytes. We also show that the migration of type 1 diabetes monocytes towards the lymphoid tissue-related CCL19 was increased and correlated with an increased CCR7 surface expression on the monocytes. Because NOD mice show a high expression of these lymphoid tissue-related chemokines in the early pancreas it is more likely that the early macrophage and dendritic cell accumulation in the diabetic pancreas is related to an aberrant high expression of lymphoid tissue-related chemokines in the pancreas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045741      PMCID: PMC1809454          DOI: 10.1111/j.1365-2249.2005.02865.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

Review 1.  The chemokine system: redundancy for robust outputs.

Authors:  A Mantovani
Journal:  Immunol Today       Date:  1999-06

2.  Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice.

Authors:  J G Rosmalen; F Homo-Delarche; S Durant; M Kap; P J Leenen; H A Drexhage
Journal:  Lab Invest       Date:  2000-05       Impact factor: 5.662

3.  Influence of extracellular matrix proteins on the development of cultured human dendritic cells.

Authors:  U Brand; I Bellinghausen; A H Enk; H Jonuleit; D Becker; J Knop; J Saloga
Journal:  Eur J Immunol       Date:  1998-05       Impact factor: 5.532

4.  Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.

Authors:  S A Litherland; X T Xie; A D Hutson; C Wasserfall; D S Whittaker; J X She; A Hofig; M A Dennis; K Fuller; R Cook; D Schatz; L L Moldawer; M J Clare-Salzler
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

5.  Diabetes-prone NOD mice show an expanded subpopulation of mature circulating monocytes, which preferentially develop into macrophage-like cells in vitro.

Authors:  Tatjana Nikolic; Gerben Bouma; Hemmo A Drexhage; Pieter J M Leenen
Journal:  J Leukoc Biol       Date:  2005-03-23       Impact factor: 4.962

6.  Differential chemokine receptor expression and function in human monocyte subpopulations.

Authors:  C Weber; K U Belge; P von Hundelshausen; G Draude; B Steppich; M Mack; M Frankenberger; K S Weber; H W Ziegler-Heitbrock
Journal:  J Leukoc Biol       Date:  2000-05       Impact factor: 4.962

7.  NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation.

Authors:  Gerben Bouma; Tatjana Nikolic; Jojanneke M C Coppens; Cornelia G van Helden-Meeuwsen; Pieter J M Leenen; Hemmo A Drexhage; Silvano Sozzani; Marjan A Versnel
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

Review 8.  The regulatory role of MRP8 (S100A8) and MRP14 (S100A9) in the transendothelial migration of human leukocytes.

Authors:  C Kerkhoff; I Eue; C Sorg
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

9.  Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse.

Authors:  Sacha Brigitte Geutskens; Françoise Homo-Delarche; Jean-Marie Pleau; Sylvie Durant; Hemmo Arjan Drexhage; Wilson Savino
Journal:  Cell Tissue Res       Date:  2004-10-05       Impact factor: 5.249

10.  Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate.

Authors:  M Thivierge; C Le Gouill; M J Tremblay; J Stanková; M Rola-Pleszczynski
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

View more
  16 in total

1.  Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice.

Authors:  Ian Y Zhang; Hui Zhou; Huili Liu; Leying Zhang; Hang Gao; Shunan Liu; Yanyan Song; Darya Alizadeh; Hongwei Holly Yin; Raju Pillai; Behnam Badie
Journal:  Clin Cancer Res       Date:  2020-02-04       Impact factor: 12.531

2.  Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes.

Authors:  Tiziana Cabras; Elisabetta Pisano; Andrea Mastinu; Gloria Denotti; Pietro Paolo Pusceddu; Rosanna Inzitari; Chiara Fanali; Sonia Nemolato; Massimo Castagnola; Irene Messana
Journal:  Mol Cell Proteomics       Date:  2010-06-28       Impact factor: 5.911

3.  S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation.

Authors:  Michelle M Averill; Shelley Barnhart; Lev Becker; Xin Li; Jay W Heinecke; Renee C Leboeuf; Jessica A Hamerman; Clemens Sorg; Claus Kerkhoff; Karin E Bornfeldt
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

4.  Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.

Authors:  Vikram Sharma; Kulbhushan Tikoo
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

5.  S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus.

Authors:  Ryo Kawakami; Shunsuke Katsuki; Richard Travers; Dayanna Carolina Romero; Dakota Becker-Greene; Livia Silva Araujo Passos; Hideyuki Higashi; Mark C Blaser; Galina K Sukhova; Josef Buttigieg; David Kopriva; Ann Marie Schmidt; Daniel G Anderson; Sasha A Singh; Luis Cardoso; Sheldon Weinbaum; Peter Libby; Masanori Aikawa; Kevin Croce; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-28       Impact factor: 8.311

Review 6.  Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.

Authors:  Sherman S Leung; Josephine M Forbes; Danielle J Borg
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

7.  Mycelial forms of Coccidioides spp. in the parasitic phase associated to pulmonary coccidioidomycosis with type 2 diabetes mellitus.

Authors:  B Muñoz-Hernández; M A Martínez-Rivera; G Palma Cortés; A Tapia-Díaz; M E Manjarrez Zavala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-30       Impact factor: 3.267

8.  Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.

Authors:  Fredrik Johansson; Farah Kramer; Shelley Barnhart; Jenny E Kanter; Tomas Vaisar; Rachel D Merrill; Linda Geng; Kazuhiro Oka; Lawrence Chan; Alan Chait; Jay W Heinecke; Karin E Bornfeldt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-05       Impact factor: 11.205

9.  Altered phenotype of peripheral blood dendritic cells in pediatric type 1 diabetes.

Authors:  Janne K Nieminen; Jukka Vakkila; Harri M Salo; Nina Ekström; Taina Härkönen; Jorma Ilonen; Mikael Knip; Outi Vaarala
Journal:  Diabetes Care       Date:  2012-07-11       Impact factor: 19.112

10.  Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis.

Authors:  Marina Dunaeva; Stefan Voo; Carolien van Oosterhoud; Johannes Waltenberger
Journal:  Basic Res Cardiol       Date:  2009-07-24       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.